How should investors evaluate Longboard Pharmaceuticals Inc (NASDAQ:LBPH)?

Stocks of Longboard Pharmaceuticals Inc (NASDAQ:LBPH) traded higher last session on Wall Street, up 0.54% to $59.40.

LBPH stock price is now 65.73% away from the 50-day moving average and 125.29% away from the 200-day moving average. The market capitalization of the company currently stands at $2.31B.

Top 5 Artificial Intelligence Stocks to Buy for 2024

By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it. According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

Sponsored

With the price target of $60, Truist recently initiated with Buy rating for Longboard Pharmaceuticals Inc (NASDAQ: LBPH). On July 01, 2024, Cantor Fitzgerald reiterated its ‘Overweight’ rating on the stock by increasing its target price from $60 to quote $90, while ‘Robert W. Baird’ rates the stock as ‘Outperform’

In other news, Kaye Randall, CMO sold 16,667 shares of the company’s stock on Oct 15 ’24. The stock was sold for $983,936 at an average price of $59.03. Upon completion of the transaction, the CMO now directly owns 17,920 shares in the company, valued at $1.06 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Sep 16 ’24, CMO Kaye Randall sold 16,666 shares of the business’s stock. A total of $527,318 was realized by selling the stock at an average price of $31.64. This leaves the insider owning 17,920 shares of the company worth $1.06 million. A total of 13.69% of the company’s stock is owned by insiders.

During the past 12 months, Longboard Pharmaceuticals Inc has had a low of $3.60 and a high of $59.12. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 20.95, and a quick ratio of 20.95. The fifty day moving average price for LBPH is $35.3542 and a two-hundred day moving average price translates $26.098625 for the stock.

The latest earnings results from Longboard Pharmaceuticals Inc (NASDAQ: LBPH) was released for 2024-06-30.

Related Posts